Opportunity ID: 335834

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-22-028
Funding Opportunity Title: Limited Competition:Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 21, 2021
Last Updated Date: Sep 21, 2021
Original Closing Date for Applications: Oct 27, 2021
Current Closing Date for Applications: Oct 27, 2021
Archive Date: Dec 02, 2021
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. See Funding Opportunity Announcement for Full Eligibility Details. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to maintain the Data Coordinating Center (DCC) for the Caenorhabditis Intervention Testing Program (CITP,) to coordinate data collection and analysis among the laboratories participating in the CITP, and to provide public access to standard operating procedures and experimental outcomes (including an accessible, annotated, and user-friendly database). The purpose of the CITP is to test, under standardized conditions at a consortium of three sites, potential intervention strategies that may moderate/alleviate health declines associated with aging across genetically diverse species and strains of Caenorhabditis. The CITP will continue to use lifespan and indicators of locomotory health as criteria for efficacious impact by targeting mechanisms likely to be conserved across phyla, but will combine compound sets derived from multiple sources, including those proposed by the biology of aging research community. The goals of next phase of the CITP are to: 1) increase the capacity to screen compounds with a high standard of rigor and reproducibility; 2) evaluate and, if warranted, implement new technologies, protocols, and genetic models of Caenorhabditis to enhance the throughput and depth of the CITP; 3) measure transcriptomic profiles to provide additional information on compounds that are effective in multiple species and/or strains, or on compounds that are effective in only a subset of species or strains; 4) develop reporters of various aging hallmarks in genetically diverse Caenorhabditis strains; and 5) use identified reporters to develop phenotypic screens against hallmarks of aging as a novel paradigm for anti-aging compounds that can have multiple uses in basic research as well as generate unique platforms for translational research.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-028.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00269069 Sep 27, 2021 Jan 24, 2022 View

Package 1

Mandatory forms

335834 RR_SF424_2_0-2.0.pdf

335834 PHS398_CoverPageSupplement_5_0-5.0.pdf

335834 RR_OtherProjectInfo_1_4-1.4.pdf

335834 PerformanceSite_2_0-2.0.pdf

335834 RR_KeyPersonExpanded_2_0-2.0.pdf

335834 RR_Budget_1_4-1.4.pdf

335834 PHS398_ResearchPlan_4_0-4.0.pdf

335834 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

335834 RR_SubawardBudget30_1_4-1.4.pdf

335834 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T03:13:26-05:00

Share This Post, Choose Your Platform!

About the Author: